Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Factor IX Deficiency Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Factor IX Deficiency Treatmentmarket, defines the market attractiveness level of Factor IX Deficiency Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Factor IX Deficiency Treatment industry, describes the types of Factor IX Deficiency Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Factor IX Deficiency Treatment market and the development prospects and opportunities of Factor IX Deficiency Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Factor IX Deficiency Treatment market in Chapter 13.
By Player:
Pfizer
Biogen
Novo Nordisk
CSL Behring
Shire
By Type:
Hemophilia B
Hemophilia B Inhibitors
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Factor IX Deficiency Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Factor IX Deficiency Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Factor IX Deficiency Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Factor IX Deficiency Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Factor IX Deficiency Treatment Market Analysis and Outlook to 2022
-
7.1 Global Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.2 United States Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.3 Europe Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.4 China Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.5 Japan Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.6 India Factor IX Deficiency Treatment Consumption (2017-2022)
-
7.7 South Korea Factor IX Deficiency Treatment Consumption (2017-2022)
8 Region and Country-wise Factor IX Deficiency Treatment Market Analysis and Outlook to 2028
-
8.1 Global Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.2 United States Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.4 China Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.6 India Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Factor IX Deficiency Treatment Consumption Forecast (2022-2028)
9 Global Factor IX Deficiency Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Factor IX Deficiency Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hemophilia B Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Factor IX Deficiency Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Factor IX Deficiency Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Factor IX Deficiency Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hemophilia B Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Factor IX Deficiency Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Factor IX Deficiency Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Factor IX Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Factor IX Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Factor IX Deficiency Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Factor IX Deficiency Treatment Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Factor IX Deficiency Treatment Product and Service
-
14.2 Biogen
-
14.2.1 Biogen Company Details
-
14.2.2 Biogen Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biogen Factor IX Deficiency Treatment Product and Service
-
14.3 Novo Nordisk
-
14.3.1 Novo Nordisk Company Details
-
14.3.2 Novo Nordisk Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novo Nordisk Factor IX Deficiency Treatment Product and Service
-
14.4 CSL Behring
-
14.4.1 CSL Behring Company Details
-
14.4.2 CSL Behring Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CSL Behring Factor IX Deficiency Treatment Product and Service
-
14.5 Shire
-
14.5.1 Shire Company Details
-
14.5.2 Shire Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Shire Factor IX Deficiency Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Factor IX Deficiency Treatment
-
Figure Factor IX Deficiency Treatment Picture
-
Table Global Factor IX Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Factor IX Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Factor IX Deficiency Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Factor IX Deficiency Treatment Consumption by Country (2017-2022)
-
Figure United States Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Factor IX Deficiency Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Factor IX Deficiency Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Factor IX Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia B Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia B Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia B Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Factor IX Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Factor IX Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Factor IX Deficiency Treatment Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Factor IX Deficiency Treatment Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Factor IX Deficiency Treatment Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Factor IX Deficiency Treatment Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Factor IX Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Factor IX Deficiency Treatment Product and Service
-
